Reporter

April 6, 2021

U.S. government reserves supply of COVID-19 antibody cocktail discovered at VUMC

The U.S. government has reserved up to 700,000 doses of a monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca, officials have announced.

By Bill Snyder
April 5, 2021

New Clinician Spotlight: Robert Ramirez

Robert Ramirez, DO, a thoracic and neuroendocrine oncologist, has joined Vanderbilt-Ingram Cancer Center after practicing at Ochsner Medical Center and Louisiana State University (LSU) Health Science Center in New Orleans.

By VUMC News and Communications
April 2, 2021

Study links ADHD pharmacotherapy and retention rates for substance use disorder treatment

Kristopher Kast, MD, assistant professor in the Department of Psychiatry and Behavioral Sciences and clinical director of Vanderbilt’s Addiction Consult Service, has discovered a strong association between attention-deficit/hyperactivity disorder (ADHD) pharmacotherapy and retention rates for substance use disorder (SUD) treatment.

By Emily Stembridge
Vials with medication and syringe on blue methacrylate table. Horizontal composition. Top elevated view.
April 2, 2021

Investigational vaccine to be tested against COVID-19 variant

Vanderbilt University Medical Center is participating in a national phase 1 clinical trial in healthy adults of an investigational vaccine against the B.1.351 variant of the COVID-19 virus that was first identified in South Africa.

By Bill Snyder
April 1, 2021

COVID-19 met with intensive teamwork

Team members serving COVID-19 inpatients were more densely connected, interacting far more than their medical ICU counterparts.

By Paul Govern
April 1, 2021

Novel way to neutralize Rift Valley Fever Virus

The discovery of monoclonal antibodies that neutralize Rift Valley Fever Virus — an emerging infection with pandemic potential — lays the foundation for future therapeutic antibody development.

By Bill Snyder
April 1, 2021

COVID recovery included long stay on ECMO, double-lung transplant

Zach Lloyd was only 37 years old with no pre-existing health conditions, but COVID-19 was bringing him within an inch of his life.
By Matt Batcheldor
April 1, 2021

Breast cancer cells ‘steal’ nutrients from immune cells: study

Triple-negative breast cancer cells engage in a “glutamine steal” — outcompeting T cells for the nutrient glutamine and impairing their ability to kill tumor cells, Vanderbilt researchers have discovered.
By Leigh MacMillan
April 1, 2021

Study outlines VUMC’s strategy for a learning health care system

New investments in clinical programs at Vanderbilt University Medical Center are increasingly contingent upon studies to validate claims of benefit and the potential for scalability and spread.
By Paul Govern
April 1, 2021

Study shows new COVID target could improve vaccines

Despite an impressive vaccination effort that exceeds 2 million shots a day, rates of COVID-19 are again on the rise in several parts of the United States, as is the spread of highly transmissible variants of the virus.
By Bill Snyder
April 1, 2021

Analysis seeks to better manage infection in dialysis patients

Analysis seeks to better manage infection in dialysis patients
By Emily Stembridge
April 1, 2021

Schools of Medicine, Law rise in 2022 U.S. News rankings

Vanderbilt University’s graduate programs showed continued strength in the 2022 U.S. News & World Report Best Graduate Schools rankings, which were released this week.
By VUMC News and Communications
April 1, 2021

Stone lands faculty development award

The American Academy of Allergy, Asthma and Immunology Foundation has awarded a three-year, $240,000 Faculty Development Award to Cosby Stone Jr., MD, MPH, instructor in Medicine at Vanderbilt University Medical Center.
By Paul Govern
1 … 144 145 146 147 148 … 725